On January 9th, the launch ceremony of the China ASEAN Medical Regional Procurement Platform was held in Fangchenggang City, Guangxi. It is reported that this platform is the first cross-border pharmaceutical regional centralized procurement platform guided by the National Medical Security Administration for local construction. The construction of the platform will empower the high-level open development of the Fangchenggang International Medical Open Experimental Zone and promote the "going global" of Chinese medicine. The China ASEAN Medical Regional Centralized Procurement Platform is an information service platform that carries domestic and international medical centralized procurement business, realizing the full process management of drugs, medical consumables, etc. from centralized procurement to settlement. Liao Pinhu, Vice Chairman of Guangxi Zhuang Autonomous Region, introduced that Guangxi has completed high-quality construction of the China ASEAN regional pharmaceutical procurement platform, online "Guangxi Medical Insurance Cloud Platform+N", and China Medical Insurance Health Exhibition Hall, laying a solid foundation for carrying out procurement work for ASEAN and other countries. It is reported that relying on the China ASEAN regional centralized procurement platform for pharmaceuticals, Guangxi will actively promote the entry of domestically produced drugs and medical consumables into ASEAN countries, and innovate the establishment of convenient service channels for purchasing drugs at home and abroad, gradually meeting the real-time online drug purchasing needs of insured persons in Guangxi, medical personnel outside the region, and cross-border medical groups in ASEAN countries. China and ASEAN countries are connected by mountains and rivers, and have a close cultural connection. Shi Zihai, Deputy Director of the National Healthcare Security Administration, stated at the launch ceremony that the official launch of this platform marks a substantial step forward in the exchange and cooperation between China and ASEAN countries in the field of pharmaceutical procurement. It will provide broader cooperation space for both sides in the field of pharmaceutical procurement and make positive contributions to enhancing the health and well-being of both peoples. The Fangchenggang International Medical Open Experimental Zone was announced to be established at the first International Medical Innovation Cooperation Forum in May 2019. It is reported that Guangxi will give full play to the advantages of Fangchenggang International Medical Open Pilot Zone, promote pharmaceutical enterprises to "bring in" and "go out", focus on cultivating transnational medical cooperation brands with strong market competitiveness and international influence, promote the implementation of more "small and beautiful" medical and health projects, better serve to build a closer China ASEAN community of shared future and jointly build the "the Belt and Road" with high quality. (New Society)